Enveloped/flu Flashcards
Production of enveloped virus
viral RNA -> protein -> Golgi -> cell membrane
virion -> membrane ->
BUDS OFF!
not lysis - cell doesn’t die immediately (vs non-enveloped)
Envelope
Lipids - from host cell membrane
Proteins - from virus genome -> specificity for receptors
Appears clear with “rods” = proteins
Enveloped vs non-enveloped
Antigens - envelope protein vs capsid protein
Envelope -
- sensitive to ether, organic solvents (-> lipids)
- unstable outside of host (dessication vs fecal oral capside crystal)
Release via budding (not fatal) vs lysis of cell
Structure of flu virus
Enveloped orthomyxo
- proteins = hemagglutinin (antigen, binds to host sialic acid)
= neuraminidase (target for antiviral)
RNA - 8 strands, (-) strand (not mRNA)
- each strand in separate helical nucleocapsid
RNA-dependent RNA polymerase
Classes of enveloped viruses
Paramyxo Toga Herpes Flavi Orthomyxo (flu) Rhabdo Retro Pox Hepadna
Hemagglutination assay
Orthomyxoviruses contain hemagglutinin protein (HA)
- HA binds sialic acid on RBC’s -> complex vs “button”
- inhibited by antibody (neutralizes HA -> button)
Can assess:
- viral concentration (dilution that still forms complex)
- antibody concentration (dilution that prevents complex)
Flu antigens
Capsids - around RNA segments but hidden!
Hemagglutinin (HA) - necessary for adsorption (binds to sialic acid)
- can be neutralized by Ab
Neuramidinase (N) - necessary for release of new virions
(cleaves sialic acid-HA bonds)
- Ab slows spread (to other cells, people) but does not neutralize virions or prevent infection of new cells
Types of flu
3 types (A,B,C) - defined by capsid protein (A,B,C) Antigenic differences within type - HA, NA, polymerases, etc
A - most serious, epidemic q2-3 years, pandemic q10-30 years
B - less serious, epidemic q3-6 years
C - not significant
Vaccine = 2 A + B
Minor epidemics
Antigenic drift = minor mutation in existing RNA
- usually mistake in HA gene -> conformational change
- some existing antibodies bind (partial immunity)
Major pandemic
Antigenic shift of HA antigen (genetic reassortment)
- existing antibodies can’t neutralize -> no preexisting immunity
Sometimes N antigen also shifts
-> more severe bc N antibody can’t slow down spread
Diagnosis of flu
Rapid - fluorescent antibodies -> throat swab
Normal - seroconversion (increase in anti-HA antibodies)
Definitive - culture in eggs or tissue -> isolate
Flu clinical presentation
Aerosol spread (cough, sneeze) -> URI (can cause -> lower respiratory)
Destroys ciliated cells (can cause -> Pneumococcus pneumonia)
Inflammatory mediators -> fever, chills, H/A
Does NOT spread through viremia
Death - infant, elderly, previous lung compromise
- 1918 young adults died: strong immune response -> lung damage
Immunity to flu
Does not spread by viremia! (infects local resp tissues only)
- > short incubation period (days)
- > main protection is secreted IgA
- we are better at neutralizing viremic vs local…
Flu vaccine
Trivalent (2 A strains + 1 B) Strains selected in anticipation of epidemic Killed (formaldehyde) -> IM injection -> only induces IgG response - no IgA produced! sub-optimal
Also have intranasal attenuated (separate slide)
Attenuated flu vaccine
aka FluMist 2 A strains + 2 B strains Attenuated - can't grow at body temperature Intranasal spray -> IgA response! more effective! Approved for ages 2-49